F. Brun-Vézinet

Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing

Anne–Mieke Vandamme, Anders Sönnerborg, Mounir Ait‐Khaled et al. · Antiviral Therapy · 2004 · 144 citations · Full text

Pharmacotherapy, Resistance Testing, Clinical Use +17

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro

Bénédicte Roquebert, Florence Damond, Gilles Collin et al. · Journal of Antimicrobial Chemotherapy · 2008 · 126 citations

Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)

Maurizio Zazzi, Rolf Kaiser, Anders Sönnerborg et al. · HIV Medicine · 2010 · 49 citations · Full text

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

Pierre Frange, Lambert Assoumou, Diane Descamps et al. · Journal of Antimicrobial Chemotherapy · 2015 · 44 citations · Full text

Phi Patients, Immunodeficiencies, First-line Strategies +17

HIV Type 1 Genetic Diversity and Genotypic Drug Susceptibility in the Republic of Moldova

Ivona Pandrea, Diane Descamps, Gilles Collin et al. · AIDS Research and Human Retroviruses · 2001 · 34 citations

Genetic Epidemiology, Immunology, Subtype B Infection +17